A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CCFN SEC filings page.
Muncy Columbia Fncl (CCFN) reported $75.6M in revenue over the twelve months to Sep 30, 2026, up 11.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 shows a liability-funded financial business where earnings convert to cash while equity grows faster than assets.
FY2025 operating cash flow of$23.3M nearly matched net income of$24.2M , so reported earnings were broadly realized in cash rather than held in accruals. Free cash flow reached$21.9M while capital expenditures were$1.4M , indicating the current model requires modest reinvestment relative to cash generation.
The FY2023 shock reads as an interruption rather than a continuing margin decline: net profit margin fell
The balance sheet is structurally liability-funded: liabilities were
Financial Health Signals
We do not publish a peer-relative financial health score for Muncy Columbia Fncl, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Muncy Columbia Fncl passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
Key Financial Metrics
Earnings & Revenue
Muncy Columbia Fncl generated $18.2M in revenue in Q3 2026. This represents a decrease of 1.6% from the same quarter a year earlier. Against the prior quarter it is down 5.6%.
Muncy Columbia Fncl reported $6.0M in net income in Q3 2026. This represents a decrease of 10.1% from the same quarter a year earlier. Against the prior quarter it is down 15.5%.
Muncy Columbia Fncl earned $0.57 per diluted share (EPS) in Q3 2026. This represents a decrease of 9.5% from the same quarter a year earlier. Against the prior quarter it is down 14.9%.
Not reported for Q3 2026.
Cash & Balance Sheet
Muncy Columbia Fncl generated $7.2M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 3.5% from the same quarter a year earlier. Against the prior quarter it is up 50.3%.
Muncy Columbia Fncl held $35.8M in cash as of Q3 2026; no long-term debt figure is on record for that period.
Muncy Columbia Fncl paid $0.16 per share in dividends in Q3 2026. This represents an increase of 3.3% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Muncy Columbia Fncl's net profit margin was 33.1% in Q3 2026, showing the share of revenue converted to profit. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.9 percentage points.
Muncy Columbia Fncl's quarterly ROE was 3.1% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
Muncy Columbia Fncl invested $113K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 23.1% from the same quarter a year earlier. Against the prior quarter it is down 86.3%.
Not reported for Q3 2026.
Not reported for Q3 2026.
CCFN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.2M-1.6% | $19.3M+13.4% | $18.9M+16.1% | $19.1M+18.4% | $18.5M+19.7% | $17.0M+15.3% | $16.3M+12.8% | $16.1M+53.0% |
| Interest Expense | $6.3M-8.9% | $6.6M-3.3% | $6.5M-7.4% | $6.6M-11.1% | $7.0M-13.3% | $6.9M-12.5% | $7.0M-12.3% | $7.5M+22.0% |
| Income Tax | $1.2M-11.4% | $1.4M+16.5% | $1.5M+97.0% | $1.6M+83.6% | $1.4M+49.4% | $1.2M+37.5% | $767K+10.4% | $859Kn/m |
| Net Income | $6.0M-10.1% | $7.2M+24.0% | $7.2M+64.7% | $7.4M+41.5% | $6.7M+32.9% | $5.8M+22.5% | $4.3M+7.7% | $5.2Mn/m |
| EPS (Basic) | $0.57-9.5% | $0.67+24.1% | $0.67+64.2% | $0.70+42.2% | $0.63+33.1% | $0.54+22.7% | $0.41+8.8% | $0.49 |
| EPS (Diluted) | $0.57-9.5% | $0.67+24.1% | $0.67+64.2% | $0.70+42.2% | $0.63+33.1% | $0.54+22.7% | $0.41+8.8% | $0.49 |
| Diluted Shares (Avg) | N/A | N/A | N/A | N/A | N/A | N/A | 11M-1.1% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
CCFN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B+2.0% | $1.7B+3.5% | $1.7B+7.2% | $1.7B+4.8% | $1.7B+3.0% | $1.6B+1.5% | $1.6B+1.8% | $1.6B-2.7% |
| Cash & Equivalents | $35.8M-21.1% | $20.1M-50.5% | $60.4M+154.4% | $48.5M+179.3% | $45.3M+61.5% | $40.7M+89.6% | $23.8M+46.4% | $17.4M-5.4% |
| Goodwill | $25.6M0.0% | $25.6M0.0% | $25.6M0.0% | $25.6M0.0% | $25.6M0.0% | $25.6M0.0% | $25.6M0.0% | $25.6M0.0% |
| Total Liabilities | $1.5B+1.7% | $1.5B+2.3% | $1.5B+6.6% | $1.5B+3.6% | $1.5B+2.3% | $1.4B+0.4% | $1.4B+0.9% | $1.4B-3.8% |
| Long-Term Debt | N/A | N/A | $40.6M | $40.6M-26.9% | $40.5M | $45.5M | N/A | $55.5M |
| Total Equity | $193.0M+4.6% | $198.7M+12.7% | $192.1M+12.1% | $192.5M+15.7% | $184.5M+9.0% | $176.3M+11.8% | $171.4M+10.7% | $166.4M+8.2% |
| Retained Earnings | $131.3M+15.6% | $126.9M+17.0% | $121.4M+14.5% | $119.4M+15.6% | $113.6M+14.0% | $108.4M+12.8% | $106.0M+14.0% | $103.3M+14.1% |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.
CCFN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.3M-3.8% | $5.6M+8.9% | $16.6M+252.9% | $5.9M+30.3% | $7.6M+84.3% | $5.1M+16.6% | $4.7M+21.3% | $4.5M+307.4% |
| Capital Expenditures | $113K-23.1% | $827K+59.7% | $101K-82.5% | $154K+27.3% | $147K+65.2% | $518K+516.7% | $576K+409.7% | $121K-76.3% |
| Free Cash Flow | $7.2M-3.5% | $4.8M+3.2% | $16.5M+299.7% | $5.7M+30.4% | $7.4M+84.7% | $4.6M+6.9% | $4.1M+9.6% | $4.4M+635.7% |
| Investing Cash Flow | -$11.5Mn/m | $6.6M-9.9% | -$42.1M-1484.6% | -$12.5Mn/m | -$31.0M-3666.0% | $7.3Mn/m | $3.0M-95.3% | -$4.3M-123.2% |
| Financing Cash Flow | $19.8M-29.2% | -$52.5M-1273.2% | $37.4Mn/m | $9.8Mn/m | $28.0M+1631.4% | $4.5M-67.2% | -$1.4Mn/m | -$10.9Mn/m |
| Dividends Paid | $1.6M+3.5% | $5.2M+54.3% | $1.6M+2.4% | $1.6M+2.4% | $1.6M+1.2% | $3.4M+113.4% | $1.6M+1.3% | $1.6M+73.8% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Share Buybacks.
CCFN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 33.1%-3.1pp | 37.0%+3.2pp | 37.8%+11.2pp | 38.8%+6.3pp | 36.2%+3.6pp | 33.8%+2.0pp | 26.6%-1.3pp | 32.4%+43.7pp |
| Return on Equity | 3.1%-0.5pp | 3.6%+0.3pp | 3.7%+1.2pp | 3.8%+0.7pp | 3.6%+0.7pp | 3.3%+0.3pp | 2.5%-0.1pp | 3.1%+3.9pp |
| Return on Assets | 0.4%-0.1pp | 0.4%+0.1pp | 0.4%+0.1pp | 0.4%+0.1pp | 0.4%+0.1pp | 0.4%+0.1pp | 0.3%0.0pp | 0.3%+0.4pp |
| Debt-to-Equity | N/A | N/A | 0.21 | 0.21-0.1x | 0.22 | 0.26 | N/A | 0.33 |
| Liabilities-to-Equity | 7.75-0.2x | 7.42-0.8x | 7.94-0.4x | 7.69-0.9x | 7.97-0.5x | 8.17-0.9x | 8.35-0.8x | 8.59-1.1x |
| Asset Turnover | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x |
| FCF Margin | 39.3%-0.8pp | 24.7%-2.4pp | 87.1%+61.8pp | 30.0%+2.8pp | 40.0%+14.1pp | 27.1%-2.1pp | 25.3%-0.7pp | 27.2%+21.6pp |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Muncy Columbia Fncl CCFN | FY2025 | $71.0M | $24.2M | 34.1% | $310.5M | — |
| CSB Bancorp Inc OH CSBB | FY2025 | $49.7M | $13.4M | 26.9% | $202.3M | — |
Where Muncy Columbia Fncl Ranks
Frequently Asked Questions
Muncy Columbia Fncl (CCFN) reported $71.0M in total revenue for fiscal year 2025. This represents a 16.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Muncy Columbia Fncl (CCFN) revenue grew by 16.6% year-over-year, from $60.8M to $71.0M in fiscal year 2025.
Yes, Muncy Columbia Fncl (CCFN) reported a net income of $27.7M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $24.2M, with a net profit margin of 34.1%.
As of fiscal year 2025, Muncy Columbia Fncl (CCFN) had $48.5M in cash and equivalents against $40.6M in long-term debt.
Muncy Columbia Fncl (CCFN) had a net profit margin of 34.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, Muncy Columbia Fncl (CCFN) paid $0.77 per share in dividends during fiscal year 2025.
Muncy Columbia Fncl (CCFN) has a return on equity of 12.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Muncy Columbia Fncl (CCFN) generated $21.9M in free cash flow during fiscal year 2025. This represents a 32.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Muncy Columbia Fncl (CCFN) generated $23.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Muncy Columbia Fncl (CCFN) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.
Muncy Columbia Fncl (CCFN) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Muncy Columbia Fncl (CCFN) had a debt-to-equity ratio of 0.21 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Muncy Columbia Fncl (CCFN) had a liabilities-to-equity ratio of 7.69 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Muncy Columbia Fncl (CCFN) had a return on assets of 1.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Muncy Columbia Fncl (CCFN) trades at 11.2x earnings, its market capitalization divided by $27.7M net income, trailing 12 months to September 30, 2026. The market capitalization is $310.5M as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Muncy Columbia Fncl (CCFN) trades at 4.1x sales, its market capitalization divided by $75.6M revenue, trailing 12 months to September 30, 2026. The market capitalization is $310.5M as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Muncy Columbia Fncl (CCFN) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.